{
  "image_filename": "figure_p10_mrg_det_9_004.png",
  "image_path": "Liu_et_al.__2024_/extracted/figures/figure_p10_mrg_det_9_004.png",
  "image_type": "Figure",
  "page_number": 10,
  "block_id": "mrg_det_9_004",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Figure displaying multiple panels of ELISA-measured antibody titers (log\u2082 scale) against HA head (H3N2, H1pdm09, B/VIC, B/YAM) and HA stalk (H3 and H1 stalk) and fold-rise ratios at day 0 and 1 month post-vaccination across seven repeat vaccination arms: ccIIV4-ccIIV4, ccIIV4-RIV4, RIV4-ccIIV4, RIV4-RIV4, IIV4-ccIIV4, IIV4-RIV4, and IIV4-IIV4. does not support the claim Note: Brand names for IIV4 and ccIIV4 are not specified, and this figure appears to be from a small repeat-vaccination immunogenicity study rather than the pivotal trial comparing Flublok against Fluarix.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Figure displaying multiple panels of ELISA-measured antibody titers (log\u2082 scale) against HA head (H3N2, H1pdm09, B/VIC, B/YAM) and HA stalk (H3 and H1 stalk) and fold-rise ratios at day 0 and 1 month post-vaccination across seven repeat vaccination arms: ccIIV4-ccIIV4, ccIIV4-RIV4, RIV4-ccIIV4, RIV4-RIV4, IIV4-ccIIV4, IIV4-RIV4, and IIV4-IIV4.",
    "evidence_found": null,
    "reasoning": "does not support the claim",
    "confidence_notes": "Brand names for IIV4 and ccIIV4 are not specified, and this figure appears to be from a small repeat-vaccination immunogenicity study rather than the pivotal trial comparing Flublok against Fluarix."
  }
}